Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

11.98
Delayed Data
As of Jul 02
 -0.12 / -0.99%
Today’s Change
5.53
Today|||52-Week Range
13.84
+5.97%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash--37.8M65.2M35.8M
 
 
 
 
Short Term Investment Cash19.7M-12.7M27.4M-29.4M
 
 
 
 
 
Cash & Short Term Investments50.5M110.1M155.3M124.1M
 
 
 
 
 
 
ReceivablesReceivables7.4M9.3M5.9M3.3M
 
 
 
 
 
 
InventoriesInventories0.000.000.00----
 
Current AssetsPrepaid Expenses1.9M------
 
 
Other Current Assets5.8M9.0M5.5M4.7M
 
 
 
 
 
Current Assets65.6M128.3M166.6M132.1M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross22.3M25.3M34.9M38.6M
 
 
 
 
 
Depreciation-16.1M-19.0M-21.5M-24.1M
 
 
 
 
 
Intangible Assets13.1M12.8M11.7M11.3M
 
 
 
 
 
Other Assets13.1M13.9M11.8M11.5M
 
 
 
 
 
Total Assets85.3M149.0M192.4M158.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable4.7M283.0K1.9M2.5M
 
 
 
 
 
Short Term Debt48.0K2.4M8.2M13.3M
 
 
 
 
 
Accrued Expenses9.2M17.9M29.0M28.1M
 
 
 
 
 
Other Current Liabilities17.0M30.0M40.3M88.6M
 
 
 
 
 
Other Liabilities26.2M38.5M57.7M111.1M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.0037.5M103.4M106.8M
 
 
 
 
Deferred Taxes-1.3M0.00-507.0K-496.0K
 
 
 
 
Other Liabilities1.5M2.0M1.2M1.2M
 
 
 
 
 
Total Liabilities107.0M155.4M235.5M260.7M
 
 
 
 
 
 
EquityMinority Interest-453.0K-477.0K-240.0K-268.0K
 
 
 
 
 
Preferred Stock268.2M0.000.000.00
 
 
Common Equity-290.5M-6.5M-43.5M-102.1M
 
 
 
 
 
Total Shareholder Equity-22.3M-6.5M-43.5M-102.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding11.8M95.8M102.5M106.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account